JP2006519217A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006519217A5 JP2006519217A5 JP2006502278A JP2006502278A JP2006519217A5 JP 2006519217 A5 JP2006519217 A5 JP 2006519217A5 JP 2006502278 A JP2006502278 A JP 2006502278A JP 2006502278 A JP2006502278 A JP 2006502278A JP 2006519217 A5 JP2006519217 A5 JP 2006519217A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide according
- peptide
- treatment
- strain
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 14
- 238000004519 manufacturing process Methods 0.000 claims 4
- 241000589291 Acinetobacter Species 0.000 claims 2
- 241001453380 Burkholderia Species 0.000 claims 2
- 241000305071 Enterobacterales Species 0.000 claims 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 2
- 206010041925 Staphylococcal infections Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 239000013612 plasmid Substances 0.000 claims 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims 2
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 241000194017 Streptococcus Species 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 208000027096 gram-negative bacterial infections Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0303369A GB0303369D0 (en) | 2003-02-14 | 2003-02-14 | Antimicrobial agents |
| GB0303375A GB0303375D0 (en) | 2003-02-14 | 2003-02-14 | Antimicrobial agents |
| PCT/GB2004/000592 WO2004072093A2 (en) | 2003-02-14 | 2004-02-16 | Antimicrobial agents from streptococcus mitis and streptococcus oralis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006519217A JP2006519217A (ja) | 2006-08-24 |
| JP2006519217A5 true JP2006519217A5 (https=) | 2007-03-15 |
Family
ID=32870950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006502278A Pending JP2006519217A (ja) | 2003-02-14 | 2004-02-16 | 抗菌剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060258596A1 (https=) |
| EP (1) | EP1606309A2 (https=) |
| JP (1) | JP2006519217A (https=) |
| AU (1) | AU2004212179A1 (https=) |
| CA (1) | CA2556351A1 (https=) |
| WO (1) | WO2004072093A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0703945D0 (en) * | 2007-03-01 | 2007-04-11 | Univ Bristol | Peptide |
| US20110262508A1 (en) * | 2007-11-07 | 2011-10-27 | Paul Michael Watt | Antimicrobial compositions, formulations and uses thereof |
| US20110256179A1 (en) | 2008-11-17 | 2011-10-20 | Essum Ab | Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains |
| CA2808793C (en) * | 2010-08-31 | 2020-09-22 | Centro Superior De Investigacion En Salud Publica (Csisp) | Anti-caries compositions and probiotics/prebiotics |
| US9925257B2 (en) * | 2011-09-23 | 2018-03-27 | Forsyth Dental Infirmary For Children | Vaccine and therapeutic delivery system |
| WO2013044059A2 (en) * | 2011-09-23 | 2013-03-28 | Forsyth Dental Infirmary For Children | A vaccine and therapeutic delivery system |
| CN102994434A (zh) * | 2012-09-13 | 2013-03-27 | 安徽希普生物科技有限公司 | 重组阳离子抗菌肽g13大肠杆菌基因工程菌及其构建方法 |
| FR2999601B1 (fr) * | 2012-12-17 | 2015-01-30 | Urgo Lab | Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis |
| US11174288B2 (en) | 2016-12-06 | 2021-11-16 | Northeastern University | Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria |
| WO2026032976A1 (en) * | 2024-08-09 | 2026-02-12 | Universidade Nova De Lisboa | Streptococcus preparation for treatment of respiratory tract infection |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5447914A (en) * | 1990-06-21 | 1995-09-05 | Emory University | Antimicrobial peptides |
| US5885782A (en) * | 1994-09-13 | 1999-03-23 | Nce Pharmaceuticals, Inc. | Synthetic antibiotics |
| US6964760B2 (en) * | 1997-06-10 | 2005-11-15 | University Of Florida Research Foundation | Antimicrobial polypeptide, nucleic acid, and methods of use |
| US6218362B1 (en) * | 1997-09-08 | 2001-04-17 | Universite Laval | Lantibiotic from Streptococcus mutans and uses thereof |
| SE511648C2 (sv) * | 1998-04-17 | 1999-11-01 | Bacterum Ab | Streptokockpreparat för behandling av öroninflammation |
-
2004
- 2004-02-14 US US10/545,962 patent/US20060258596A1/en not_active Abandoned
- 2004-02-16 EP EP04711399A patent/EP1606309A2/en not_active Withdrawn
- 2004-02-16 WO PCT/GB2004/000592 patent/WO2004072093A2/en not_active Ceased
- 2004-02-16 CA CA002556351A patent/CA2556351A1/en not_active Abandoned
- 2004-02-16 AU AU2004212179A patent/AU2004212179A1/en not_active Abandoned
- 2004-02-16 JP JP2006502278A patent/JP2006519217A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102871996B (zh) | 一种抗菌药物组合物及其应用 | |
| Lee et al. | Klebsiella pneumoniae secretes outer membrane vesicles that induce the innate immune response | |
| WO2010036938A3 (en) | Nanoemulsion therapeutic compositions and methods of using the same | |
| JP2004533246A5 (https=) | ||
| JP2011504366A5 (https=) | ||
| MX352281B (es) | Dihidroxi-clorinas glico-sustituidas y clorinas beta-funcionalizadas para terapia fotodinamica anti-microbiana. | |
| JP2006519217A5 (https=) | ||
| JP2022062116A (ja) | 療法バクテリオファージ組成物 | |
| US11253557B2 (en) | Therapeutic bacteriophage compositions | |
| JP2013523718A5 (https=) | ||
| CN107022539B (zh) | 一种链球菌广谱嵌合裂解酶GBS-V12b及其编码基因和应用 | |
| Klem et al. | Bacteriophage therapy against staphylococci | |
| Magana et al. | Therapeutic options and emerging alternatives for multidrug resistant staphylococcal infections | |
| Angelakis et al. | Human case of Atopobium rimae bacteremia | |
| WO2012141674A3 (en) | Compositions and methods relating to argininosuccinate synthetase | |
| Park et al. | First Korean case of Helcococcus kunzii bacteremia in a patient with diabetes | |
| CN104971342A (zh) | 一种抗甲氧西林耐药的金黄色葡萄球菌的药物组合物 | |
| Riaz et al. | Contribution of klebseilla pneumonia to antibiotic resistance of human infection: A review | |
| JP2019510519A5 (https=) | ||
| US20210332095A1 (en) | Infection-induced endothelial amyloid compositions as antimicrobials | |
| WO2016146037A1 (zh) | 用于抑制/瓦解生物被膜的抑制剂及其应用 | |
| Gómez-Chávez et al. | Staphylococcal extracellular vesicles (EVS): function, pathogenesis, and therapy | |
| Batool et al. | Draft genome sequences of lysostaphin-resistant (K07-204) and lysostaphin-susceptible (K07-561) staphylococcus aureus sequence type 72 strains isolated from patients in South Korea | |
| Chakraborty et al. | Review on Recent Advancement of Therapeutic Interventions in Combating Multidrug Resistant Bacteria.(2020) | |
| Alwethainani et al. | Hospital microbiome: unspoken role in healthcare-associated infections |